| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06492525 A Study To Evaluate The Effect Of Rifampicin Or Ltraconazole On Pharmacokinetics Of… |
overall status: Not Yet Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06041776 | Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR… | Non-Small Cell Lung Cancer | Recruiting |
| NCT05341583 | Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small… | Non-small Cell Lung Cancer | Recruiting |
| Phase 2 | |||
| NCT07181499 | Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients… | NSCLC | Recruiting |
| NCT05007938 | Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06885840 | Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and… | Non-Small Cell Lung Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04930432 | Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced… | Solid Tumor | Recruiting |
| NCT07448116 | Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. | Solid Advanced Tumor | Recruiting |
| NCT07435038 | Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations… | Non-small Cell Lung Cancer (NSCLC) | Not Yet Recruiting |
| Phase 1 | |||
| NCT05341557 | A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or… | Advanced Solid Tumor | Recruiting |
| NCT05789602 | A Study of BPI-460372 in Advanced Solid Tumor Patients | Advanced Solid Tumor | Recruiting |
| NCT06015568 | Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell… | Non-Small Cell Lung Cancer、EGFR Sensitive Mutation | Not Yet Recruiting |
| NCT06641609 | A Phase I Study of CFT8919 in Patients With Advanced NSCLC | Non-Small Cell Lung Cancer With EGFR Mutation | Not Yet Recruiting |
| NCT03791112 | A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor | Advanced Solid Cancer | Active, Not Recruiting |